| Date Filed | Type | Description |
| 07/17/2023 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $5.13, valued at
$46.2k
|
|
| 06/05/2023 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Sold 12,500 shares
@ $8.65, valued at
$108.1k
Sold 29,480 shares
@ $8.74, valued at
$257.7k
Exercised 6,459 restricted stock units
@ $0 |
|
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/24/2023 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Sold 2,828 shares
@ $9.17, valued at
$25.9k
Sold 4,640 shares
@ $9.26, valued at
$43k
|
|
| 01/17/2023 |
3
| Freitag Gregory Gene (Director) has filed a Form 3 on ZyVersa Therapeutics, Inc. |
| 11/16/2022 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Sold 13,000 shares
@ $12.74, valued at
$165.6k
|
|
| 08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $3.9, valued at
$35.1k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Bought 5,882 shares
@ $8.5, valued at
$50k
Granted 9,000 options to buy
@ $9.95, valued at
$89.6k
|
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2020 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Granted 2,300 shares
@ $0
Sold 916 shares
@ $17.81, valued at
$16.3k
|
|
| 12/22/2020 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Granted 925 shares
@ $0
Sold 379 shares
@ $16.42, valued at
$6.2k
|
|
| 09/17/2020 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 9,000 options to buy
@ $3.67, valued at
$33k
Exercised 4,046 options to buy
@ $3.67, valued at
$14.8k
|
|
| 06/25/2020 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $1.45, valued at
$13.1k
|
|
| 06/01/2020 |
4
| Freitag Gregory Gene (General Counsel) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 125,000 options to buy
@ $3.5, valued at
$437.5k
|
|
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 38,400 shares
@ $1.3, valued at
$49.9k
|
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2019 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $5.99, valued at
$53.9k
|
|
| 03/25/2019 |
3
| Freitag Gregory Gene (Director) has filed a Form 3 on PDS Biotechnology Corp |
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/31/2018 |
4
| Freitag Gregory Gene (General Counsel) has filed a Form 4 on AxoGen, Inc.|
Txns:
| Granted 18,500 options to buy
@ $19.17, valued at
$354.6k
Granted 4,600 restricted stock units
@ $0 |
|
| 12/04/2018 |
4
| Freitag Gregory Gene (General Counsel) has filed a Form 4 on AxoGen, Inc.|
Txns:
| Sold 45,000 shares
@ $33, valued at
$1.5M
|
|
| 11/15/2018 |
4
| Freitag Gregory Gene (General Counsel) has filed a Form 4 on AxoGen, Inc.|
Txns:
| Sold 20,000 shares
@ $32.25, valued at
$645k
|
|
|